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The main objective of cancer management with chemotherapy (anticancer drugs) is to
kill the neoplastic (cancerous) cell instead of a normal healthy cell. The bioassay-guided
isolation of two new sesquiterpene coumarins (compounds 1 and 2) have been carried
out from Ferula narthex collected from Chitral, locally known as “Raw.” Anticancer activity
of crude and all fractions have been carried out to prevent carcinogenesis by using
MTT assay. The n-hexane fraction showed good activity with an IC50 value of 5.434
± 0.249µg/mL, followed by crude MeFn extract 7.317 ± 0.535µg/mL, and CHCl3
fraction 9.613 ± 0.548µg/mL. Compounds 1 and 2 were isolated from chloroform
fraction. Among tested pure compounds, compound 1 showed good anticancer activity
with IC50 value of 14.074 ± 0.414µg/mL. PASS (Prediction of Activity Spectra) analysis
of the compound 1 was carried out, in order to predicts their binding probability with
anti-cancer target. As a results the compound 1 showed binding probability with human
histone acetyltransferase with Pa (probability to be active) value of 0.303. The compound
1was docked against human histone acetyltransferase (anti-cancer drug target) by using
molecular docking simulations. Molecular docking results showed that compound 1
accommodate well in the anti-cancer drug target. Moreover the activity support cancer
chemo preventive activity of different compounds isolated from the genus Ferula, in
accordance with the previously reported anticancer activities of the genus.
Keywords: Ferula narthex Bioss, sesquiterpene coumarin, cytotoxic, anticancer potential, Prediction of Activity
Spectra, human histone acetyltransferase, and molecular docking
INTRODUCTION
Ferula narthex Bioss; family Apiaceae, is indigenous to Kandahar, Eastern Persia, Western
Afghanistan and Pakistan (Kashmir and Baltistan; Indrayan et al., 2009). In Pakistan it is found
in various localities like Gilgit, Chitral (Kamari, Damusar, Chilim, Gudai, Astore, and the hill of
Alam et al. Sesquiterpene Coumarins are Anticancer Agent
Majini Harai), locally it is known as “Raw” in Chitral (Shinwari
and Gilani, 2003). Family Apiaceae (Umbelliferae) comprises of
275 genera and 2850 species (Indrayan et al., 2009). F. narthex
Bioss. is a well-known carminative, anti-flatulence digestive spice,
much essential for Ayurvedic formulation and even for the
preparation of many Indian dishes i.e., Asafoetida botanically
known as Ferula narthex Bioss (Sengupta et al., 2004). It is an
oleogum-resin collected from rhizome and root of the plant.
It is considered as very important agent in Indian system of
medicine, especially for intestinal flatulence. It is acrid, bitter,
stimulant and mostly useful in constipation-gaseous distention
(colic pain; Sengupta et al., 2004). Local people used this plant for
cough, asthama, toothache, gastric problems and in constipation,
angina pectoris. Gum resin of Ferula narthex Bioss. is used in
hysteria, treatment of habitual abortion, whooping cough and
scorpion sting (Srinivasan, 2005; Anuar et al., 2008; Khan et al.,
2011). Extracts and pure compounds from this plant showed
anticancer (Saleem et al., 2001), antidiabetic (Iranshahy and
Iranshahi, 2011), and anti-fertility effect (Kalita et al., 2011). A
large number of active compounds have been isolated from genus
Ferula. Mainly sesquiterpene, coumarins, and sulfur containing
compounds have been previously reported (Buddrus et al., 1985;
Appendino et al., 1993; El-Razek et al., 2003; Bandyopadhyay
et al., 2006).
Different substances like foods, pharmaceuticals or some
cosmetic agents exhibited cytotoxic property. The main objective
of cancer management with chemotherapy (anticancer drugs)
is to kill the neoplastic (cancerous) cell instead of a normal
healthy cell. Different types of cells present in human as part
of immune system including natural killers, cytotoxic cells, and
lymphokine activated cells are responsible to destroy abnormal
and damaged cells (Cano et al., 2011). Any agent having
cytotoxic activity can be used in various pathological conditions
(inflammation, AIDS, infection, and cancer; Su et al., 2009). The
current studies revealed the bioassay-guided isolation of two
sesquiterpene coumarins and their anticancer potential against
PC3 cells (prostate cancer).
MATERIALS AND METHODS
Plant Material
Whole plant of F. narthex was collected from Chitral located in
Khyber Pakhtunkhwa, Pakistan, in July 2010, and was identified
by the Taxonomy section Department of Botany University of
Peshawar. A voucher specimen (BOT 20002) was submitted to
the herbarium section of the same department.
Extraction and Isolation of Compounds
The collected plant of F. narthex was air dried in shade and was
then powdered. Dry powder (8.0 kg) was extracted by methanol
Abbreviations: EtoAc, ethylacetate; MeFn, methanolic extract of Ferula narthex
Bioss; MTT, (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide);
DMEM, dulbecco-modified eagle medium; FBS, fetal bovine serum; DMSO,
dimethyl sulfoxide; IC50, 50% inhibitory concentration; SD, standard deviation;
NMR, nuclear magnetic resonance; HRESI-MS, high-resolution electrospray
ionization mass spectrometry.
as an extraction solvent at room temperature for 14 days with
daily shaking. After this it was filtered and the crude methanolic
extract (900 g) was obtained which was concentrated under
vacuum at low temperature (45◦C). Then it was partitioned
into n-hexane (70.0 g), chloroform (40.0 g), ethylacetate (29.0 g),
and butanol (34.0 g) fractions. Chloroform fraction (40.0) was
loaded onto silica gel column with increasing polarity of n-
hexane/ethylacetate, which yielded number of sub-fractions A-G
out of these fractions D (3.4 g) and E (1.3 g) obtained from 25
and 35% ethyl acetate/n-hexane respectively were resubjected to
column chromatography. Sub-fraction D was further subjected
to silica gel column by using n-hexane/acetone as eluting agent,
which yielded compound 2 (600mg) (8% acetone/n-hexane),
While compound 1 (24.0mg) was obtained from sub-fraction E
at 9% acetone/n-hexane solvent system..
Anticancer Assay
Anticancer activity of compounds was evaluated in 96-well flat-
bottomed micro plates by using the standard reduction of MTT
colorimetric assay (Dimas et al., 1998). For this purpose, PC3 cells
(prostate cancer) were cultured in DMEM, containing 5% of FBS,
100µg mL−1 of streptomycin and 100 IU mL−1 of penicillin in
25 cm3 flasks, in an incubator at 37◦C under a 5% carbon dioxide
atmosphere. The exponentially growing cells were counted with
a haemocytometer and diluted to a concentration of 1 × 105
cells mL−1. The diluted culture was then introduced into 96-
well plates (100µL well−1) with various concentrations of the
compounds in the range 1–100µM and incubated overnight.
After incubation, medium was separated and 50µL MTT (2mg
mL−1) was added to each well and incubated further for 4 h.
Subsequently, 100µL of DMSOwas added to eachwell. TheMTT
was reduced to formazan within viable cells and its absorbance
was measured at 570 nm using a microplate ELISA reader
(Spectra Max plus, Molecular Devices,CA, USA).
%inhibition = (1− Absorbancetestcompound/Absorbancecontrol)
×100
Molecular Docking
The molecular docking procedure was widely used to predict
the binding interaction of the compounds in the binding pocket
of the enzyme. The 3D crystal structure of human histone
acetyltransferase was downloaded from Protein Data Bank (PDB
ID: 4PZS) (Oikonomakos et al., 2000). All the ions and water
molecules were removed and the hydrogen atoms were added to
the enzyme by the 3D protonation using the MOE (Molecular
Operating Environment) (www.chemcomp.com) software. The
target enzyme were then energy minimized by the default
parameters of the MOE for the stability and further assessment
of the enzyme. The structures of the compounds were built in
MOE and energy minimized using the MMFF94x forcefield and
gradient: 0.05. The synthesized compounds were docked into the
active site of the target enzyme inMOE by the default parameters
i.e., Placement: Triangle Matcher, Rescoring: London dG. For
each ligand ten conformations were generated. The top-ranked
conformation of each compound was used for further analysis.
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Statistical Analysis
IC50 evaluation of only active compounds was done, serial
dilutions of test compounds were prepared with different
concentrations. A triplicate sample of each concentration was
incubated using the standard procedure described. Percentage
inhibition for each concentration was calculated. IC50 valve
is evaluated using EZ-FIT, Enzyme kinetics software (Perrella
Scientific, Inc., Hillsborough, NH, USA).
IC50-value was presented as mean± S.E.M (standard error of
the mean) calculated by using the formula
S.E.M = s√
N
where s= sample standard deviation
s =
√√√√ 1
N − 1
N∑
i=1
(xi − x)2
xi − xn = sample data set; x = mean valve of sample data; N =
size of data.
RESULTS AND DISCUSSION
Identification of Compounds
Compound 1 was isolated as a white amorphous solid from the
chloroform-soluble part of the crude extract of F. Narthex Boiss.
Its molecular formula C24H30O4 was deduced with the help of
13C NMR as well as HRESI-MS. Compound 1 (Figure 1) was
found to be a sesquiterpene coumarin. The detail spectroscopic
data of compound 1 were already reported in our previous article
(Bashir et al., 2014). All of the spectral data of compound 2 have
molecular formula C24H30O4 was found to be unambiguously
matched with the reported data for conferol, previously isolated
from Ferula pallida (Su et al., 2000).
Anticancer Activity
Natural organic compounds have extensively used as a new
pharmacophore template in drug discovery. The bio-assay
guided isolation of new anti-cancer agents (compounds 1
and 2) were performed from F. narthex. In the preliminary
step of bio-assay guided isolation the all crude fractions
were evaluated for their anti-cancer activity against PC3 cells
(prostate cancer). As a result, the n-hexane fraction showed
significant activity against PC3 cancer lines with an IC50 value
of 5.434 ± 0.249µg/mL, followed by crude MeFn extract 7.317
± 0.535µg/mL, and CHCl3 fraction 9.613 ± 0.548µg/mL
(Table 1). After fractionation of chloroform, the compounds 1
and 2 were isolated. Both the isolated compounds were also
evaluated against PC3 cancer lines by employing the same
protocol that were used for the fractions Among tested pure
compounds, only the compound 1 showed good anticancer
activity with an IC50 value of 14.074 ± 0.414µg/mL. The
remaining fractions and compound 2 showed no activity against
PC3cancer cell lines and the IC50 values of these were >30 as
presented in Table 1.
As reported previously regarding the anticancer potential of
Ferula, the oleo-gum resin of F. foetida was reported to prevent
carcinogenesis (Saleem et al., 2001). This activity support the use
of various isolated compounds from this genus for treatment of
cancer along with other co-administered anticancer agents like
TABLE 1 | Anticancer activity of crude MeFn extract and various fractions
along with pure compounds 1 and 2.
S. No. Sample IC50 ± SD (µg ml
−1)
1 MeFn 7.317 ± 0.535
2 n-hexane 5.434 ± 0.249
3 CHCl3 9.613 ± 0.548
4 EtOAc >30
5 BuOH >30
6 Aqueous >30
ISOLATED COMPOUNDS
7 1 14.074 ± 0.414
8 2 >30
9 Doxorubicin (standard) 2.8 ± 0.12
FIGURE 1 | Structures of compound 1 and 2.
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vincristine (Unnikrishnan and Kuttan, 1990; Saleem et al., 2001).
A prenylated coumarin (diversin, 1) together with four new
sesquiterpene lactones (diversolides A, D, F, and G, 2-5) isolated
from the roots of Ferula diversivittata were showed cancer chemo
preventive activity (Iranshahi et al., 2010). Galbanic acid isolated
from F. assafoetida was reported to exhibit anticancer effect (Kim
et al., 2011).
Molecular Docking Simulation
PASS (Prediction of Activity Spectra) is an online tool (Lagunin
et al., 2000), which predicts almost 900 types of activities based
on the structure of a compound. PASS analysis (Table 2) of the
compound 1 predicts anti-cancer activity (antineoplastic) with Pa
(probability to be active) value of 0.303. To evaluate the inhibitory
nature of the compound 1 as anti-cancer agent, the compound
1 was docked against human histone acetyltransferase (anti-
cancer drug target), molecular docking simulations were carried
out. Molecular docking is an efficient method to get an insight
into ligand-receptor interactions. Molecular docking studies
were performed usingMolecular Operating Environment (MOE)
software (www.chemcomp.com). The 3D crystal structure of
human histone acetyltransferase was downloaded from Protein
Data Bank (PDB ID: 4PZS) (Oikonomakos et al., 2000).
Before docking experiment, the structure of compound 1 was
prepared for docking by minimizing its energy using MOE.
Most macromolecular crystal structures contain little or no
hydrogen coordinate data due to limited resolution and thus
protonation was done prior to docking using Protonate 3D
tools implemented in MOE. Protonation was followed by energy
minimization up to 0.05 Gradient using Amber99 forcefield.
The docking protocol predicted the same conformation as
was present in the crystal structure with RMSD value close
to the allowed range (Paul and Mukhopadhyay, 2004) and
surrounded by the same active site residues of the enzyme.
Amongst the generated docking conformations the top-ranked
conformation was visualized for ligand-enzyme interaction using
MOE. Analysis of the docking results showed that compound 1
fit well within the active site of histone acetyltransferase enzyme
(Figure 2). From the docking conformation it was observed
that oxygen atom of the compound established hydrogen bond
with the active site residue Gln169. The phenyl ring of the
compound formed arene-arene interaction with the active site
residue His165 (Figure 2). Furthermore, several hydrophobic
interactions between compound 1 and the hydrophobic residues
FIGURE 2 | Docking conformation of compound 1 (generated by MOE docking software) in the active site of human histone acetyltransferase enzyme.
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TABLE 2 | PASS prediction of the compound, Pa represents probability to
be active and Pi represents probability to be inactive.
Pa Pi Predicted activity
0.288 0.017 UGT2B9 substrate
0.330 0.062 Antipsoriatic
0.266 0.007 Testosterone agonist
0.293 0.034 UGT2B17 substrate
0.351 0.093 CYP3A5 substrate
0.273 0.016 UGT2B18 substrate
0.287 0.031 UGT2B substrate
0.304 0.051 UDP-glucuronosyltransferase substrate
0.275 0.027 Cholesterol synthesis inhibitor
0.303 0.056 Antineoplastic (pancreatic cancer)
0.261 0.017 Menstruation disorders treatment
0.294 0.051 UGT1A substrate
0.280 0.040 Choleretic
0.362 0.122 Cytoprotectant
0.271 0.032 ATP-binding cassette A1 stimulant
0.293 0.060 Indanol dehydrogenase inhibitor
0.326 0.095 Analeptic
0.238 0.011 Hair growth stimulant
0.306 0.079 Antidiabetic
0.287 0.061 NF-E2-related factor 2 stimulant
The compound 1 predicts anti-cancer activity with Antineoplastic (pancreatic cancer).
of the enzyme were also observed. The presence of hydrogen
bond, arene-arene and hydrophobic interactions confirm that the
compound 1may be specific to this site. These preliminary results
suggest that the compound 1 might exhibit inhibitory activity
against histone acetyltransferase enzyme. These computational
predictions are verified by our experimental results in the
compound 1 showed good anti-cancer activity (Table 1).
CONCLUSION
The anticancer activity showed that F. narthex can be used in
the management of cancer as n-hexane fraction, crude MeFn,
CHCl3 fraction, and pure compound 1 showed good to moderate
anticancer activity against PC3 cancer lines. Moreover the activity
support the use of different compounds isolated from the genus
Ferula as anticancer agents.
Mathematical Formula
Standard deviation
s =
√√√√ 1
N − 1
N∑
i=1
(xi − x)2
xi − xn = sample data set; ; x =mean valve of sample data; N =
size of data.
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